NCT06911424: An ongoing trial by Baxis Pharmaceuticals, Inc.
This trial is ongoing. It must report results 12 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06911424 |
|---|---|
| Title | A Phase 3 Randomized, Multi-Center, Placebo-Controlled, Masked Study to Evaluate the Clinical Efficacy and Safety of Fusidic Acid 1% Viscous Topical Antibiotic Eye Drops for the Treatment of Suspected Bacterial Conjunctivitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 21, 2025 |
| Completion date | Dec. 15, 2025 |
| Required reporting date | Dec. 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |